相关实验视频

Updated: Jun 11, 2025

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

一项基因研究,以确定良性前列腺增生症的致病机制和药物标:一个多omics门德尔随机化研究

Bohan Liu¹, Xinyi Wang¹, Zerui Yang¹

¹Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology) and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, 610041, Sichuan, People's Republic of China.

Scientific reports

|October 4, 2024

概括

这项研究整合了多omics数据,以确定良性前列腺增生症 (BPH) 中的关键基因和途径. 研究人员发现BTN3A2和C4A是高度自信的基因和BPH的潜在治疗点.

科学领域:

泌尿器科泌尿器科泌尿器科泌尿器科
遗传学遗传学是一个
免疫学免疫学免疫学
代谢学代谢学代谢学

背景情况:

良性前列腺增生 (BPH) 是一种常见的老年病,患病率越来越高.
目前的BPH治疗因有效性有限和并发症风险而面临挑战.
导致BPH的确切致病机制尚不清楚,阻碍了治疗进展.

研究的目的:

通过使用多omics方法识别与BPH相关的新生物分子和致病途径.
发现高可信度基因和BPH的潜在治疗点.
探索免疫路径和代谢物在BPH发病过程中的作用.

主要方法:

基因组学,转录组学,免疫学和代谢学数据的整合.
转录组归算,基于总结数据的门德尔随机化 (SMR) 和其他统计分析的应用.
对免疫和代谢因素的DNA甲基化位点,可药物基因和门德尔随机化 (MR) 的分析.

主要成果:

在血液和前列腺组织中,BTN3A2和C4A被确定为与BPH相关的高自信基因.
一个涉及cg14345882-BTN3A2的特定致病途径得到了阐明.
确定了30个有前途的治疗点,包括BTN3A2和C4A. 免疫因子IL-17和特定的代谢物 (cysteinylglycine disulfide/氧化,脂酸盐) 与增加BPH风险有关.

结论:

这项多学科研究成功地确定了与BPH相关的关键基因,途径和代谢物.
BTN3A2和C4A是BPH干预的有希望的治疗点.
这些发现为开发BPH新型诊断和治疗策略提供了基础.

关键词:

良性前列腺增生症良性前列腺增生症药物目标是药物目标.门德尔的随机化多个omics的多个omics.病原性机制的病原性机制

更多相关视频

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Murine Prostate Micro-dissection and Surgical Castration

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...